Mach7 Technologies Ltd (ASX: M7T) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Mach7 Technologies Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $79.61 million
P/E Ratio 1,428.57
Dividend Yield 0.00%
Shares Outstanding 241.24 million
Earnings per share -0.033
Dividend per share N/A
Year To Date Return -58.23%
Earnings Yield 0.07%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Mach7 Technologies Ltd (ASX: M7T)
    Latest News

    Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
    Small Cap Shares

    3 small cap ASX shares to buy for massive returns

    Analysts are tipping these buy-rated stocks to deliver the goods for investors over the next 12 months.

    Read more »

    A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
    Small Cap Shares

    3 small cap ASX shares to buy for very big returns

    Analysts are tipping these buy-rated stocks to deliver the goods for investors over the next 12 months.

    Read more »

    A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
    52-Week Lows

    Why I think this ASX penny stock is a bargain at its 52-week low

    This health tech share hasn't been feeling the love from the market lately. But is there an upside on the…

    Read more »

    a concerned medical doctor examines an Xray from an imaging machine in a hospital setting.
    Earnings Results

    Can this ASX healthcare stock, down 22% in a year, turn the tide after FY24 results?

    How did this ASX healthcare company do in FY24?

    Read more »

    Rising share price chart.
    Small Cap Shares

    3 small cap ASX stocks that could rise 40% to 100%+

    Brokers believes these small caps could be worth a closer look.

    Read more »

    A woman wearing glasses and a black top smiles broadly as she stares at a money yarn full of coins representing the rising JB Hi-Fi share price and rising dividends over the past five years
    Small Cap Shares

    Morgans rates these ASX small-cap shares as best buys

    Big returns could be on the cards for buyers of these small caps according to the broker.

    Read more »

    Three young people in business attire sit around a desk and discuss.
    Small Cap Shares

    3 ASX penny stocks I don't think will be below 80 cents much longer

    These sub-dollar shares are all capable of smashing through to another level, say experts.

    Read more »

    a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
    Healthcare Shares

    Why this little ASX healthtech share is charging 7% to a 52-week high on Friday

    This health technology share is making its shareholders smile on Friday

    Read more »

    Broker looking at the share price on her laptop with green and red points in the background.
    Small Cap Shares

    Broker says these small cap ASX shares offer big returns potential

    These small cap ASX shares could provide big returns for investors over the next 12 months...

    Read more »

    two people sit side by side on a rollercoaster ride with their hands raised in the air and happy smiles on their faces
    Best Shares

    Top ASX shares to buy in January 2023

    Investing in some quality ASX shares to kick off the new year could be just the ticket...

    Read more »

    A businessman leaps in the air outside a city building in the CBD.
    Healthcare Shares

    Mach7 signs $17 million contract – share price jumps 20% at open

    Shares in the ASX listed medical imaging systems provider leapt more than 20% on open.

    Read more »

    A young man sits at his desk working on his laptop with a big smile on his face due to his ASX shares going up and in particular the Computershare share price
    Share Gainers

    Why AGL, Invictus Energy, Maas, and Mach7 shares are pushing higher today

    These ASX shares are having positive days...

    Read more »

    Frequently Asked Questions

    No,  this ASX small-cap share has never paid dividends.

    Mach7 Technologies has been listed on the ASX since 30 November 2005.

    M7T ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Mach7 Technologies Ltd

    Mach7 Technologies Ltd (ASX: M7T) is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organisations. Its systems create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. This allows healthcare enterprises to identify, connect, and share diagnostic image and patient care intelligence.

    Mach7 has more than 150 customers in 15 countries and derives a majority of its revenue from North America.

    M7T Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    20 Dec 2024 $0.33 $0.01 3.08% 1,150,798 $0.33 $0.34 $0.33
    19 Dec 2024 $0.33 $-0.01 -3.03% 1,388,223 $0.34 $0.34 $0.33
    18 Dec 2024 $0.33 $0.00 0.00% 534,016 $0.33 $0.34 $0.33
    17 Dec 2024 $0.33 $0.01 3.13% 1,156,629 $0.32 $0.34 $0.32
    16 Dec 2024 $0.32 $-0.01 -3.08% 219,358 $0.33 $0.33 $0.32
    13 Dec 2024 $0.33 $-0.01 -3.03% 456,864 $0.33 $0.33 $0.31
    12 Dec 2024 $0.33 $-0.01 -2.94% 314,096 $0.34 $0.34 $0.33
    11 Dec 2024 $0.34 $0.00 0.00% 310,916 $0.36 $0.36 $0.33
    10 Dec 2024 $0.34 $-0.02 -5.63% 905,798 $0.36 $0.36 $0.34
    09 Dec 2024 $0.36 $-0.01 -2.78% 452,766 $0.36 $0.37 $0.36
    06 Dec 2024 $0.36 $-0.01 -2.74% 435,134 $0.37 $0.37 $0.36
    05 Dec 2024 $0.37 $0.01 2.78% 260,883 $0.36 $0.37 $0.36
    04 Dec 2024 $0.36 $0.00 0.00% 401,797 $0.37 $0.37 $0.36
    03 Dec 2024 $0.36 $-0.01 -2.70% 272,426 $0.37 $0.37 $0.36
    02 Dec 2024 $0.37 $0.01 2.74% 391,883 $0.37 $0.38 $0.37
    29 Nov 2024 $0.37 $-0.02 -5.26% 638,360 $0.38 $0.38 $0.36
    28 Nov 2024 $0.38 $0.02 5.56% 1,123,208 $0.37 $0.39 $0.36
    27 Nov 2024 $0.36 $-0.01 -2.74% 369,683 $0.37 $0.37 $0.36
    26 Nov 2024 $0.37 $0.00 0.00% 249,381 $0.37 $0.37 $0.37
    25 Nov 2024 $0.37 $0.02 5.71% 581,961 $0.35 $0.37 $0.35
    22 Nov 2024 $0.35 $-0.01 -2.82% 134,841 $0.36 $0.36 $0.35
    21 Nov 2024 $0.36 $-0.01 -2.78% 461,295 $0.36 $0.36 $0.35
    20 Nov 2024 $0.36 $0.00 0.00% 75,704 $0.36 $0.36 $0.36

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    12 Dec 2024 Mike Lampron Buy 46,000 $16,330
    On-market trade.
    09 Dec 2024 Mike Lampron Issued 800,000 $284,000
    Issue of securities. 2,223,000 Performance Rights
    05 Dec 2024 Robert Bazzani Buy 54,700 $19,998
    On-market trade.
    03 Dec 2024 Robert Bazzani Buy 27,395 $9,999
    On-market trade.
    02 Dec 2024 Robert Bazzani Buy 53,333 $19,962
    On-market trade.
    28 Nov 2024 Rebecca Thompson Buy 400,000 $148,000
    On-market trade.
    19 Nov 2024 Eliot Siegel Expiry 25,000 $9,000
    Options expired.
    19 Nov 2024 Mike Lampron Expiry 750,000 $270,000
    Options expired.
    19 Nov 2024 Robert Bazzani Expiry 225,000 $81,000
    Options expired.
    30 Sep 2024 Mike Lampron Expiry 402,185 $223,212
    As advised by the company. 1,423,000 Performance Rights, lapsed
    21 May 2024 Robert Bazzani Buy 29,400 $19,944
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Eliot L Siegel Non-Executive Director Aug 2018
    Dr. Siegel is a thought leader in the world of radiology and imaging informatics and artificial intelligence applications in medicine. He is currently Professor at the University of Maryland School of Medicine, Department of Diagnostic Radiology, and also works for the Veterans Affairs Maryland Healthcare System, in Baltimore, MD as well as adjunct professor of computer science and biomedical engineering at the undergraduate campuses of the University of Maryland. He is a pioneer and co-founder of United Theranostics, a company created to bring state-of-the-art radiopharmaceuticals to patients for cancer therapy. Under his guidance, the VA Maryland Healthcare System became the first filmless healthcare enterprise in the World. He has written over 300 articles and book chapters about PACS (Picture Archiving and Communication Systems) and digital imaging, and has edited books on the topic, including Filmless Radiology and Security Issues in the Digital Medical Enterprise. He has given more than 1,000 presentations throughout the world on a range of topics involving the use of computers in medicine and artificial intelligence. Dr. Siegel was symposium chairman for the Society of Photo-optical and Industrial Engineers (SPIE) Medical Imaging Meeting for three years and has been honored as a fellow in that organisation as well as the American College of Radiology and the Society of Imaging Informatics in Medicine. He is also a Board member of Carestream Health and serves on advisory boards in medical imaging. He us Risk Management Committee member. Former directorships (last 3 years): Carestream Health.
    Mr Mike Lampron Chief Operating OfficerChief Executive OfficerManaging Director Mar 2019
    Mr. Lampron is the CEO of Mach7 Technologies. With over 20 years of experience in business and operational management for Healthcare IT companies, Michael brings experience ranging from private start-up organizations as well as established companies such as IBM and GE. Michael was previously the Chief Executive Officer for a National Teleradiology Company and has ability to drive results through a combination of astute analysis, innovative execution and cross-functional teamwork. Michael is responsible for our customers' success while driving excellence throughout Mach7. Former directorships (last 3 years): Watchtower Consultants, LLC.
    Mr Robert John Bazzani Non-Executive Director Jan 2020
    Mr Bazzani spent 20 years with the global consulting firm KPMG, where he rose to the top and served as Chairman of KPMG Victoria, National Managing Partner for KPMG Australia's Enterprise Division and National Managing Partner for KPMG's M&A Division. Whilst in these roles, Rob was a member of KPMG's National Executive Committee (NEC), which oversees and is responsible for the Firm's turnover, strategic decision making, profitability and operations. Rob has a track record of leading and growing businesses. He has played a role in advising clients (public, private, and global subsidiaries) on commercial matters, public transitions, corporate governance, investment banking and law, M&A and has engaged with Government and Regulators. With experience in corporate advisory, Rob has deep commercial and industry knowledge across financial services, asset and wealth management, technology, property, insurances and consumer & industrial markets. He is Risk Management Committee member.
    Mr Peter Gundy Non-Executive Director Nov 2023
    --
    Ms Rebecca Thompson Non-Executive Director Nov 2023
    Ms Thompson has more than 25 years of financial markets experience gained at global investment banks, listed companies and a fintech start-up. Rebecca's executive career included seven years at J.P, Morgan as the Head of Corporate Broking followed by a role at KPMG Australia as the Head of Capital Advisory and most recently Head of Investor Relations for CSR Limited (ASX:CSR). Rebecca has a skillset across equities, property, and foreign exchange with experience in the real estate, building materials, healthcare, resources and software industries. Stakeholder relations, communications, sustainability and financial analysis are core competencies Other current directorships: Independent Community Living Australia (ICLA), Non-Executive Director; MarketMeter, Non-Executive Director. He is risk Management Committee Chair.
    Mr Tony Panther Company Secretary Feb 2023
    -
    Tony Panther Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    National Nominees Limited 32,877,317 13.63%
    Sandhurst Trustees Ltd (Jmfg Consol A/C) 31,114,880 12.90%
    J P Morgan Nominees Australia Pty Limited 27,668,371 11.47%
    HSBC Custody Nominees (Australia) Limited 22,684,257 9.40%
    Citicorp Nominees Pty Limited 9,721,484 4.03%
    Ubs Nominees Pty Ltd 9,233,020 3.83%
    Pt Dwi Satrya Utama 4,392,959 1.82%
    Padmalwar Prakash 3,569,921 1.48%
    Chew & Partners (Import & Export) Pte Ltd 2,900,074 1.20%
    Perco Group Pty Ltd (F S P A/C) 2,840,000 1.18%
    Microequities Asset Management Pty Ltd (Microeqts Nanocap No 11 A/C) 2,823,641 1.17%
    BNP Paribas Nominees Pty Ltd (Ib Au Noms Retailclient) 1,718,707 0.71%
    Supernatural Super Pty Ltd (The Supernatural Super A/C) 1,715,500 0.71%
    Albert Liong Pak-Fai 1,544,189 0.64%
    Bpnt Pty Ltd (Heaney Family Super Fund A/C) 1,539,283 0.64%
    Ty Webb Pty Ltd (Ty Webb A/C) 1,339,444 0.56%
    BNP Paribas Noms Pty Ltd 1,303,411 0.54%
    Mrs Jennifer Lee Pilcher 1,294,856 0.54%
    62 Darlinghurst Road Pty Ltd 1,000,000 0.41%
    HSBC Custody Nominees (Australia) Limited (Gsco Customers A/C) 964,287 0.40%

    Profile

    since

    Note